Resultados de la búsqueda 491-500 of 10656 for Hepatitis C
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...
African Americans, Afro-Caribbeans, Hispanic Blacks, and Africans are more likely to have the APOL1 gene variants that cause kidney disease. APOLLO will test ...
Hepatitis B vaccine: What to know to protect yourself Jan. 22, 2024, 03:30 p.m. CDT · Born at less than a pound, 22-week preemie makes journey from NICU to ...
Si usted no tiene hepatitis B, es probable que pueda volver a donar sangre. En Estados Unidos, la Administración de Alimentos y Medicamentos de Estados Unidos ...
The purpose of this research trail is to study the genetic alteration/mutation and immune profiling in surgical resected Non-small Cell Lung Cancer (NSCLC) ...
In patients that require a kidney transplant and bladder reconstruction, this study seeks to use a bladder graft from a deceased donor rather than intestine.
This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...
Cancer. Quarterly eNewsletter that focuses on trends and advances in hematology and oncology at Mayo Clinic · Cardiovascular · Clinical Updates · Digestive ...
Hepatitis B vaccine: What to know to protect yourself Jan. 22, 2024, 03:30 p.m. CDT · Mayo Clinic Minute: Penicillin allergy? Maybe not Jan. 18, 2024, 04:00 ...
Genetic testing can be performed in utero, but there is risk to the pregnancy and the fetus. Although some fetuses present with arrhythmias easily recognized as ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?